US Patent 7968687 CD19 binding agents and uses thereof

Is a

Patent

Patent attributes

Current Assignee

Seagen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

79686870

Patent Inventor Names

Charles G. Cerveny0

Charlotte McDonagh0

Dennis Benjamin0

Paul Carter0

Date of Patent

June 28, 2011

Patent Application Number

122538950

Date Filed

October 17, 2008

Patent Citations Received

‌

US Patent 12121589 Anti-CD19 antibody drug conjugates

‌

US Patent 11767365 BCMA antibodies and use of same to treat cancer and immunological disorders

‌

US Patent 11866496 Humanized anti-CD79B antibodies and immunoconjugates and methods of use

‌

US Patent 11931414 Quaternized nicotinamide adenine dinucleotide salvage pathway inhibitor conjugates

‌

US Patent 11938194 Cysteine mutated antibodies for conjugation

‌

US Patent 11944689 Drug conjugates with self-stabilizing linkers having improved physiochemical properties

‌

US Patent 12016842 Methods of using anti-CD79b immunoconjugates

Patent Primary Examiner

‌

Misook Yu

Patent abstract

This invention relates to CD 19 binding agents and methods of using such CD 19 binding agents for treating disease.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 7968687 CD19 binding agents and uses thereof

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 7968687 CD19 binding agents and uses thereof